Turlington's Balsam of Life

oral · 1744–1804

category:oral

delivery:A proprietary balsam of twenty-seven ingredients (later reduced) steeped in an alcohol solution, taken by mouth in drops and also applied to cuts and bruises; sold in a distinctive embossed, pear-shaped bottle from 1754 to deter counterfeiters.

price tier:not classified

era:1744–1804

current status:historical

regulatory:unregulated

SHORT PITCH (AS SOLD)

A patented 1744 balsam advertised in its patent as a cure for the stone, gravel, colic, and 'inward weakness,' and promised by accompanying pamphlets as 'certain relief' for rheumatism, gout, consumption, asthma, nervous disorders, and wounds.

THE ACTUAL EVIDENCE

No source in this bundle documents a contemporaneous controlled trial of the balsam against any disease it was advertised to treat. The 2016 archaeological history by Olive Jones and Allen Vegotsky notes that, in its own time, the balsam was consistent with then-current medical practice and would have been considered appropriate for treating many of the disorders its advertising claimed -- a period-context observation, not a modern efficacy finding. A 2013 legal-history account of the 1785 Medicine Stamp Act names Turlington's Balsam among over eighty schedule-listed proprietary preparations and characterizes that class of remedies generally as 'unproven, sometimes useless, frequently dangerous.' A 2025 Australian Pharmacist review states plainly that, given the balsam's many ingredients and its wide range of claimed uses, 'it's difficult to say how effective the balsam truly was,' and that balsamic resins of this kind show at best anti-inflammatory, antioxidant, and antimicrobial effects in modern assessment -- far short of the claimed cures for stones or consumption. A 1959 Smithsonian history (Griffenhagen and Young) quotes the United States Dispensatory's judgment that the balsam's modern unofficial descendant, Compound Tincture of Benzoin, was 'recommended in chronic dysentery ... but is of doubtful utility' for that chronic dysentery recommendation, not for internal use generally and not for the broader range of conditions the original balsam claimed to cure.

PRACTITIONERS

Robert Turlington

INGREDIENTS

Gum Benzoin (Benjamin)

CASES

turlington-balsam-of-life-1744-1766

CLAIMS

Turlington's patented Balsam of Life cures the stone, gravel, colic, and inward weakness. unreplicated
The 1750 testimonial pamphlet widens the balsam's promise well beyond the four conditions named in the patent, framing it as a restorer of decayed constitutions and printing testimonial letters, one of which credits it with curing an apprehended consumption. unreplicated
A colonial newspaper advertisement for the balsam sold under Turlington's patent claims it has 'true merit, of universal experience, utility and reputation,' superior to 'all the other known Balsams,' and is 'the best adapted in all cases, in every climate, to relieve the various ailments and diseases of the human body.' unreplicated

SOURCES

NOTES

Turlington’s Balsam of Life was a proprietary alcohol-based balsam patented by Robert Turlington in London in 1744 and sold under his own name for the rest of his life, then under other hands until at least 1804. The patent specification listed twenty-seven ingredients steeped in rectifying spirits — storax, coriander seed, aloes, fennel, mastic, cardamom, frankincense, aniseed, gum benjamin (benzoin), angelica, gum elemi, cinnamon, guaiacum, cloves, myrrh, nutmeg, araback, winter’s bark, Peru balsam, nettle seed, Tolu balsam, juniper, saffron, mace, oil, St John’s wort, and marsh mallow, per the ingredient list recorded on a period bottle held at Mackinac State Historic Parks — and asserted the balsam cured “stone, gravel, cholick, and inward weakness.” An accompanying pamphlet widened the promise considerably: quoted directly in a 2025 Australian Pharmacist account, which describes an undated 46-page testimonial pamphlet sold with each bottle, it claimed the balsam was “a certain relief for the gravel, cholic, rheumatism, gout, and sciatic pains, and all colds, coughs, consumptive, pectoral, asthmatical, and nervous disorders, &c. and for any cut, bruise, or the like.” Colonial resellers advertised it under Turlington’s patent into the 1770s. The 1785 Medicine Stamp Act’s supplementing schedule named “Turlington’s Balsam” by name among over eighty taxed proprietary preparations. No source in this bundle documents a controlled study of the formula; a 2025 professional-pharmacy review puts the ceiling for balsams of this kind at anti-inflammatory, antioxidant, and antimicrobial effects, far below the cures advertised, and a 1959 Smithsonian history records its closest surviving pharmacopoeial descendant, Compound Tincture of Benzoin, as “of doubtful utility” for the chronic dysentery use the United States Dispensatory recommended it for.